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SECTION 4
 
SIGNIFICANCE OF EEG CHANGES ASSOCIATED WITH SPACE FLIGHT:
 
COMPARATIVE STUDIES OF NORMAL INDIVIDUALS AND SUBJECTS
 
UNDERGOING PROLONGED BED REST
 
4.1. SUMMARY
 
In order to provide comparative data for further assessment of the EEG
 
alterations seen during Skylab, two investigations were conducted: (1) the
 
variability of alpha, beta, theta, and delta EEG characteristics was assessed
 
with quantitative computer techniques in a group of six normal individuals
 
over a period of two months, and (2) the EEG effects of a prolonged period of
 
bed rest were evaluated in two subjects.
 
The results have provided quantitative information which confirms that
 
the inflight EEG changes seen during Skylab were statistically significant,
 
but the absolute values obtained for the various parameters did not exceed
 
the maximal range expected in a normal population. Further, the EEG manifes­
tations of extended bed rest did not appear similar to those of space flight.
 
4.2. INTRODUCTION
 
The purpose of this investigation was (1) to define, in precise terms,
 
the variability of alpha, theta, beta, and delta EEG characteristics in a
 
group of normal control individuals, and (2) to determine the effects of
 
a prolonged period of bed rest (28 days) upon selected EEG parameters. The
 
objective of these tasks was to provide quantitative information which would
 
permit a more definitive statement to be made concerning the significance,
 
and possibly eventually the etiology, of certain EEG alterations observed in
 
recordings from Skylab astronauts (see Final Report, Part III, Contract
 
RAS 9-13870).
 
In routine clinical practice, the alpha rhythm is considered to be quite
 
stable over time in normal subjects. Variations of more than ±0.5 Hz are
 
unusual. Yet, during Skylab, inflight individual values of more than 1.0 Hz
 
above the preflight mean were observed, appearing in the early inflight
 
period. Other Skylab findings, including inflight increases in amount of
 
beta and delta activity during the awake state, have been shown to be
 
statistically significant. These EEG alterations have been difficult to
 
assess clinically, because the precise range of variability of these param­
eters in the normal population has not been documented. In the studies
 
described below, six normal subjects were evaluated repeatedly over a period
 
of two months, in order to establish such norms.
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Bed rest has long been used as a potential analog of the weightless
 
state and has been used in attempts to study the effects of zero g upon
 
human physiology. Since bed rest is accompanied by changes in the distri­
bution of body fluids (i.e., a loss from the lower extremities) that are
 
somewhat similar to those seen in space flight, but is not accompanied by
 
the vestibular or proprioceptive alterations inherent in the zero-g environ­
ment, it has been particularly valuable in attempts to understand the
 
etiology of the medical problems encountered in Skylab. Although EEG has
 
been recorded during several prior bed-rest studies, there has been no
 
evaluation of frequency and amplitude characteristics sufficient to permit
 
a quantitative comparison with the Skylab results. In several studies
 
(Ryback and Lewis, 1971; Ryback et al., 1971a, b), alterations in sleep
 
patterns were observed during prolonged bed rest (primarily, an increase
 
in stages 3 and 4), but measures of EEG characteristics were not reported.
 
EEGs were recorded by Zubek and Wilgosh (1963) in a one-week study of
 
immobilization in ten subjects. (The subjects were allowed to get up briefly
 
at certain specified times.) They reported a decrease in alpha frequency of
 
approximately 0.5 Hz at the end of the test period, compared to the pretest
 
baseline averages, a result opposite to the effect observed during Skylab.
 
Similar findings were reported in a 62-day bed-rest study by Petukhov and
 
Purakhin (1968).
 
In 1976, NASA conducted a study in which several individuals were con­
fined to bed for a period of 28 days. As a part of this study, EEG was re­
corded, in order to evaluate sleep characteristics (see Final Report, Part II,
 
Contract NAS 9-13870). This EEG information has been restudied, using quan­
titative methods, in order to provide additional information pertaining to
 
the Skylab EEG alterations.
 
A third study, involving EEG recording during parabolic flight and other
 
periods of vestibular stress, was originally a part of this contract. By re­
cording EEG during experimentally induced periods of near weightlessness as
 
well as during periods of altered vestibular function, we had hoped to deter­
mine the possible existence of direct vestibular influences upon the electro­
encephalogram. Unfortunately, the NASA program involving the use of parabolic
 
flight was curtailed in the fall of 1976, and it was not possible to obtain
 
recordings in flight. Contract funds scheduled for this portion of the program
 
were, with the consent of the contract technical monitor, redistributed to per­
mit an expanded analysis of the EEG data obtained during the normative study
 
(see section 4.4.1., below).
 
4.3. METHODS
 
4.3.1. EEG Variability in Normal Control Subjects
 
4.3.1.1. Subjects. Six volunteer subjects were selected to participate
 
in the variability study. No subject with a history of significant medical or
 
psychiatric disorder was accepted, and subjects taking medication or other
 
drugs in dosages sufficient to influence EEG characteristics were excluded.
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A summary of the volunteer 	group is provided below.
 
Medication Use Dates of
 
Subject Age Sex During Study Test Protocol
 
C.H. 	 48 M Motrin, 400 mg, q.i.d., 11/5- 11/1-12/23, 1976
 
11/18; occasional Ascriptin
 
G.K. 27 M 	 Occasional ASA 11/1-12/23, 1976
 
E.B. 	 23 X Occasional APC, ASA; 1/10-3/3, 1977
 
Lomotil, 1/27-1/29, 2/15
 
C.S. 	 24 F 1/2 gr thyroid/day; occa- 11/1-12/23, 1976
 
sional ASA
 
J.R. 	 22 F Dimacol, 1/9/77; occasional 1/10-3/3, 1977
 
Tylenol, ASA
 
S.G. 23 F 	 1/11-3/4, 1977
 
4.3.1.2. EEG Recording. EEGs were recorded under standardized conditions,
 
using conventional techniques and the international system of electrode place­
ment (The ten twenty electrode system, 1958). Analysis was performed on the
 
following electrode derivations: Fl-Al, F2-A 2 , Cl-Al, C2-A2, 01-Al, 02-A2,
 
C1-O, and C2-02.
 
Each EEG recording session lasted approximately 30 min. Environmental
 
stimuli were minimized and standardized across subjects. Each subject was
 
studied at the same time of the day during all examination sessions, to minimize
 
possible circadian variations in EEG characteristics. All signals were recorded
 
on magnetic tape, to permit later off-line analysis of selected epochs from
 
eyes-open and eyes-closed conditions.
 
The protocol for each monitoring session was as follows:
 
1. Eyes closed, relaxed (0.5-1 min)
 
2. Eyes open, relaxed (1-2 min)
 
3. Eyes open, reading (7-8 min)
 
4. Eyes open, watching television (10-15 min)
 
5. Eyes closed, relaxed (1-2 min)
 
During each of the above conditions, a 30-sec epoch was chosen for com­
puter analysis. For the purposes of this study, only data from the eyes-closed,
 
relaxed conditions was utilized, since they most closely duplicated the presleep
 
Skylab periods for which comparable data is available. Data obtained while
 
reading and watching television may be utilized in future studies of EEG varia­
tions associated with specific tasks.
 
Each subject initially was studied on four consecutive days, to establish
 
the degree of short-term variability. Subsequently, the individual was
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evaluated twice weekly, with at least two and no more than three days' interval
 
between tests, over a period of two months. Thus, each person was tested on
 
18 occasions.
 
4.3.1.3. Data Analysis. The data was analyzed in essentially the same
 
manner as were the Skylab recordings, as reported in Part III of this Final
 
Report. The general method chosen for quantification of the EEG background
 
activity has been developed in this laboratory over the past ten years (e.g.,
 
Carrie, 1969; Carrie and Frost, 1971, 1973; Frost, 1969, 1975; Frost et al.,
 
1973).
 
The system developed permits simultaneous analysis of eight EEG channels,
 
with each channel being considered in four discrete frequency bands (alpha,
 
beta, theta, and delta). Thus, in terms of digital processing, it is actually
 
a 32-channel acquisition system. The final output of the computational system
 
includes the following parameters:
 
1. 	Overall average amplitude value within each of the four
 
frequency ranges
 
2. 	The frequency component which has the largest average ampli­
tude in each frequency band, and the actual average amplitude
 
value
 
3. 	Average number of waves detected per second in each frequency 
- range 
4. 	The mean, mode, and standard deviation of the wavelength
 
distribution for each frequency band
 
For a complete description of the analysis scheme, please refer to Final
 
Report, Part III, Contract NAS 9-13870, pages 4 through 6.
 
4.3.2. EEG Effects of Prolonged Bed Rest
 
4.3.2.1. Subjects. From the group of six healthy volunteer subjects who
 
participated in the 28-day bed-rest study, two were chosen to take part in the
 
EEG and sleep evaluations:
 
Medication Use
 
Subject Age Sex During Study Starting Date
 
J.H. 26 M 
 June 	1976
 
R.T. 28 M 	 June 1976
 
4.3.2.2. EEG Recording. EEG, EOG, and EMG recordings were made, using
 
standard techniques and-the conventional system of electrode placement. The
 
following derivations were recorded during each session: F1 -C3 , F2-C4 , C3-01 ,
 
C4-0 2 , EMG (submental electrode pair), and EOG (electrodes lateral to and above
 
the eye).
 
Each recording session lasted for eight hours, from approximately 11 p.m.
 
until 7 a.m. Prior to "lights out" each night, the subjects were recorded
 
under standard eyes-open and eyes-closed conditions, to obtain the data for
 
4
 
subsequent quantitative analysis.
 
All signals were recorded on magnetic tape, to permit later off-line
 
analysis. The signals also were graphically displayed during the eight-hour
 
period on a conventional EEG machine, to permit later analysis of sleep char­
acteristics.
 
The subjects were studied according to the following schedule: Prior to
 
the start of the bed-rest phase, each subject was monitored during three
 
consecutive nights of sleep, to establish baseline characteristics. During
 
the bed-rest phase, each subject was monitored for 12 nights of the 28-day
 
study. These sessions included the first three nights, the last three nights,
 
and six additional nights, spaced relatively equally throughout the remainder
 
of the bed-rest period (nights 5, 12, 16, 18, 21, and 24). Post-bed rest, each
 
subject was studied during nights one through six.
 
4.3.2.3. Data Analysis. A computer method identical to that described
 
above for the EEG variability study (Section 4.3.1.3.) was employed to analyze
 
30-sec waking EEG samples obtained during the presleep portion of each monitor­
ing session.
 
4.4. RESULTS
 
4.4.1. Variability of EEG Characteristics Over Time in Control Subjects
 
4.4.1.1. The Alpha Frequency Range (6.5-13.5 Hz). Preliminary examina­
tion of the data revealed that, as expected, the alpha activity predominated
 
in the occipital areas of all subjects (channels Cl-Al, C2-A2 , Cj-Oj, and
 
C2-02). Since a central-to-occipital derivation was used during Skylab, the
 
C-01 and C2-02 channels were selected for detailed consideration.
 
The results are summarized in Table I, which shows, for each subject, the
 
average (mean), standard deviation (sd), and range (r = highest value minus
 
lowest value) for three EEG parameters (mean frequency, average amplitude, and
 
number of waves/see), as calculated for the entire test period (i.e., each
 
value listed is the average of all 18 individual test values obtained over the
 
two-month interval). In each case, the individual values were obtained from
 
the initial eyes-closed period of the test sequence. The overall average across
 
subjects is also indicated for each measure.
 
If the C1-01 (left) channel is considered, the average subject had a mean
 
frequency value of 9.7 Hz (sd ±0.25), with a maximum range of 0.7 Hz; an aver­
age amplitude of 14.9 iV (sd ±2.96), with a range of 11.3 pV; and averaged 8.1
 
waves/sec over the observation period (sd ±0.4), with a range of 1.6 waves/sec.
 
On the right side (C2-02), the mean frequency value was 9.8 Hz (sd ±0.27), with
 
a range of 1.0 Hz; the average amplitude was 15.9 VV (sd ±3.13), with a 12.2 pV
 
range; and the number of waves/sec averaged 8.2 (sd ±0.46), with a range of
 
1.5 waves/sec. The two sides thus tended to be quite similar, both with respect
 
to actual values and in terms of variability over time.
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A graphic presentation of the variability of these measures over time
 
for the C1-01 EEG channel of each subject is provided by Figs. 1-6. In each
 
figure, the solid line represents the data from which the values of Table I
 
(for the C1-01 channel) were derived, while the dashed line plots the values
 
obtained from the second eyes-closed period of each day. Thus, the extent to
 
which the solid and dashed tracings diverge provides an estimate of the degree
 
of variability to be expected within a time span measured in minutes (typically,
 
25-30 min). In most cases, the values for the initial and final eyes-closed
 
periods are quite similar for all parameters (e.g., Subject G.K., Fig. 2;
 
Subject E.B., Fig. 3) or show a random relationship over time (e.g., Subject
 
J.R., Fig. 5). In one individual (Subject C.H., Fig. 1), the alpha frequency
 
was consistently lower during the second eyes-closed period, perhaps reflect­
ing a tendency to become drowsy late in the monitoring session.
 
4.4;1.2. The Beta Frequency Range (13.51-40 Hz). The beta frequency
 
range results for channels Cl-01 and C2-02 are summarized in Table II, which
 
is organized in a manner identical to Table I (Section 4.4.1.1.).
 
The average subject had a mean beta range frequency of 19.7 Hz (sd ±0.79
 
Hz) on the left (CI-01) side, with an average maximum range of 3.2 Hz. The
 
corresponding average amplitude was 8.8 IV (sd ±1.23 1V, range 4.3 PV), and
 
the number of waves/sec was 12.4 (sd ±1.53), with a range of 5.9 waves/sec.
 
On the right (C2-02) side, the average frequency was 20.1 Hz (sd ±1.05 Hz),
 
with a range of 3.8 Hz; the average amplitude was 9.6 V (sd ±1.60 1 V), with
 
a range of 5.8 WV; and the average number of waves/see was 13.0 (sd ±1.94),
 
with a range of 7.2 waves/sec. As in the case of the alpha range, the two
 
sides tended to be almost identical in their beta characteristics.
 
Figures 7-12 show, graphically, the variability of beta range parameters
 
over the time course of the study for the C-01 channel for each subject (data
 
for the first [solid line] and last [dashed line] eyes-closed periods of each
 
examination are compared). In general, there was little, if any, consistent
 
difference between the two recording periods over the two-month study, although
 
on a given day a noticeable discrepancy might be seen. In two individuals,
 
however, there was a tendency for the average beta amplitude to be somewhat
 
higher during the final eyes-closed period of each test (Subjects G.K. and
 
S.G.).
 
4.4.1.3. The Theta Frequency Range (3.5-6.5 Hz). Table III summarizes
 
the theta range results for the CI-01 and C2-02 channels (table format like
 
that of Table I, Section 4.4.1.1.). On the left side (C-01), the overall
 
average values were as follows: mean frequency, 5.0 Hz (sd ±0.12), with a
 
range of 0.42 Hz; average amplitude, 8.5 aV (sd ±1.54 VV), with a range of
 
5.7 VV; and number of waves/sec, 2.8 (sd ±0.28), with a range of 1.1 waves/sec.
 
For the right side (M2-02), the mean frequency was 5.0 Hz (sd ±0.16 Hz), with
 
a range of 0.6 Hz; the average amplitude was 8.2 pV (sd ±1.40 pV), with a
 
range of 4.2 pV; and the number of waves/sec value was 2.8 (sd ±0.28), with
 
a range of 1.0 waves/sec. The two sides were, again, very similar in all
 
characteristics.
 
The variability of theta activity over the two-month study period is
 
illustrated in Figs.13-18 for the C1-01 channel of each subject. (Each
 
graph compares the daily results for the initial eyes-closed period [solid
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line] and the final eyes-closed period [dashed line].) While the two daily
 
periods were, in general, quite similar or varied randomly, two subjects
 
(C.H. and S.G.) tended to have fewer theta frequency waves (decreased number
 
of waves/sec) during the second eyes-closed period (Figs.13 and 18).
 
4.4.1.4. The Delta Frequency Range (0.5-3.5 Hz). The delta frequency
 
range results are summarized in Table IV for C1-01 and C2-02 derivations
 
(table format like that of Table I, Section 4.4.1.1.). For the C-01 (left)
 
channel, the overall average values were: mean frequency, 2.2 Hz (sd ±0.18
 
Hz), with a range of 0.6 Hz; average amplitude, 8.0 pV (sd ±1.31 pV), with a
 
range of 5.2 pV; and the average number of waves/sec was 1.5 (sd ±0.17), with
 
a range of 0.7 waves/sec. On the right side (C2-02), the mean frequency
 
averaged 2.2 Hz (sd ±0.14 Hz), with a range of 0.5 Hz; the average amplitude
 
was 7.7 pV (sd ±1.01 pV), with a range of 3.8 pV; and the average number of
 
waves/sec was 1.7 (sd ±0.13), with a range of 0.5 waves/sec. Again, the two
 
sides tended to be very similar in terms of their EEG characteristics.
 
Figures 19-24 illustrate the degree of variability over the study period
 
for the Cl-O 1 channel of each subject for both the initial eyes-closed (solid
 
lines) and final eyes-closed (dashed lines) recording conditions. As with the
 
other frequency ranges, there was, typically, no consistent difference between
 
the two recording periods, although apparently random variation was often
 
present.
 
4.4.2. 	Variability of EEG Characteristics Over Time in Subjects Undergoing
 
28 Days of Bed Rest
 
Samples for detailed analysis were obtained during the presleep period of
 
each monitoring session, while the subject was fully awake but in the eyes­
closed state. In order to facilitate comparisons with the normative study and
 
with the Skylab results, analysis was restricted to a single channel (Cl-0).
 
A Mann-Whitney U test was utilized in order to assess the significance of the
 
apparent changes in the various parameters during the test and post-test condi­
tions for individual subjects, compared to the baseline period. A probability
 
value of p=0.05 was considered to be statistically significant.
 
Tables V-VIII show the average values, standard deviations, and ranges of
 
the three major EEG parameters for each of the test conditions (i.e., prestudy,
 
or baseline; bed-rest phase; and the poststudy, or recovery, period). The
 
individual values from which these averages were determined are plotted over
 
the time course of the bed-rest study for each subject and for the four EEG
 
frequency ranges in Figs. 25-32. (In each of these figures, the mean value for
 
each parameter in the pretest period is projected across the test period as a
 
dashed line.)
 
4.4.2.1. Alpha Frequency Range (Table V)
 
4.4.2.1.1. Subject J.H. (Fig. 25). The mean frequency showed more
 
fluctuation during the bed-rest phase than during the prestudy session, with
 
a suggestion of two periods of elevation: one early (days I and 2) and one
 
relatively late (days 16-24). The bed-rest average value of 10.0 Hz was not,
 
however, significantly different from the prestudy value of 9.7 Hz. The
 
frequency tended to increase in the latter portion of the poststudy phase
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(days +4 to +6), and the average of 10.1 Hz was significantly elevated, com­
pared to the prestudy mean (p<0.05).
 
A greater range of amplitude values was also observed during bed
 
rest, but there were no significant changes in the mean values, either during
 
bed rest or in the poststudy period.
 
The number of waves/sec measure averaged 8.5 in the prestudy phase
 
and was significantly elevated in both the bed-rest period (9.5, P<0.02) and
 
the post-test phase (9.6, p<0.05).
 
4.4.2.1.2. Subject R.T. (Fig. 26). There were no significant altera­
tions or obvious trends in the mean frequency or number of waves/see measures.
 
The average amplitude values were likewise not significantly altered; however,
 
there was a transient elevation near the end of the bed-rest period (days 26­
28), which persisted into the poststudy phase (days +1 and +2).
 
4.4.2.2. Beta Frequency Range (Table VI)
 
4.4.2.2.1. Subject J.H. (Fig. 27). There were no significant altera­
tions detected during the bed-rest or poststudy periods, and no trends were
 
evident in the plots of the individual values.
 
4.4.2.2.2. Subject R.T. (Fig. 28). The mean frequency and number of
 
waves/sec parameters were not significantly altered over the course of the study.
 
The average amplitude tended to decrease slightly during bed rest (not signifi­
cant) and was significantly (p<0.02) depressed in the poststudy period (9.3 pV
 
prestudy, 7.7 pV poststudy).
 
4.4.2.3. Theta Frequency Range (Table VII)
 
4.4.2.3.1. Subject J.H. (Fig. 29). While there were no statistically
 
significant changes in any of the measured variables, there was a tendency for
 
the number of waves/sec values to be slightly decreased during the bed-rest
 
period, with a recovery in the poststudy phase.
 
4.4.2.3.2. Subject R.T. (Fig. 30). There were no significant altera­
tions seen over the course of the study, and no obvious trends.
 
4.4.2.4. Delta Frequency Range (Table VIII)
 
4.4.2.4.1. Subject J.H. (Fig. 31). No significant changes in the
 
delta frequency range parameters were seen during or following the bed-rest
 
study.
 
4.4.2.4.2. Subject R.T. (Fig. 32). The mean frequency measure tended
 
to decline slightly during the bed-rest period (prestudy 2.2 Hz, bed rest 2.0 Hz),
 
reaching a minimum value on day 12. This finding was, however, not statistically
 
significant. The average amplitude rose from 6.3 pV in the prestudy period to
 
8.3 pV during bed rest (2<0.05), then declined to a baseline level in the post­
study period.
 
No significant change in the number of waves/sec measure was observed.
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4.5. DISCUSSION: A REASSESSMENT OF THE SKYLAB FINDINGS
 
As outlined in a previous report (Part III, Final Report, Contract
 
NAS 9-13870), several waking EEG alterations were found in Skylab crew
 
members. The most consistent findings were an inflight increase in the
 
amounts of beta and theta frequency activity and an elevation of the aver­
age alpha frequency. 
The current results, obtained from individuals under
 
controlled l-g conditions, may be utilized as a reference data set against
 
which the Skylab values may be compared.
 
4.5.1. The Alpha Frequency Range
 
Two of the Skylab astronauts (O.G. and E.G.) had significant (p<0.05)

increases in the average alpha frequency parameter, inflight. The third
 
(J.K.) had a similar but nonsignificant trend. Subject E.G. (84-day flight)

showed the most clear-cut alterations: The preflight average frequency was
 
9.2 Hz, with a range of 0.8 Hz (8.9 to 9.7 Hz). Inflight, the average value
 
rose to 9.8 Hz, with a range of 1.0 Hz (10.3 Hz to 9.3 Hz). The highest in­
flight value, 10.3 Hz, was seen on the first inflight recording day (day 3)

and represented a 1.2 Hz change from the last-obtained preflight value (9.1

Hz). 
 The overall range, preflight, inflight, and postflight, was 1.4 Hz
 
(8.9 Hz to 10.3 Hz).
 
Examination of Table I shows that one of the six individuals of the norma­
tive study (S.G.) had an alpha frequency range as great as that found in Skylab

astronaut E.G., and another (Subject E.B.) 
showed a range only slightly lower
 
(1.3 Hz, C2-02 channel). Thus, considering only total range of the alpha

frequency measure, it must be concluded that the Skylab results are within the
 
range expected in a normal population.
 
Although these results indicate that the Skylab frequency range itself
 
is apparently not atypical, the pattern with which the individual values
 
occurred over time was shown to be statistically significant by application of
 
a nonparametric statistical evaluation (Mann-Whitney U test). Thus, the
 
cluster of inflight values was more consistently elevated above the preflight

grouping than would be expected by random selection within the established
 
total range (p<0.05, in the case of E.G. and O.G.).
 
This latter aspect may be compared with the results of the bed-rest study
(Table V). 
 Neither subject of this study had a total range of alpha frequency

values as great as that of Skylab Subject E.G. (J.H. = 1.2 Hz, R.T. = 0.7 Hz).

In addition, in neither case was the bed-rest period marked by a significant

elevation of the alpha frequency, compared to the prestudy portion, although

Subject J.H. had transient elevations near the beginning and end of the study.
 
Based upon these comparisons, it may be concluded that, with respect to
 
the alpha frequency measure: (1) the Skylab findings are within the overall
 
range of variation to be expected in a normal, earth-based population, but
 (2) within this normal range, the Skylab inflight values tend to be clustered
 
near the upper portion of the normal range in a nonrandom distribution, and
 
further (3) such clustering was not associated with periods of prolonged bed
 
rest in a l-g environment.
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4.5.2. The Beta Frequency Range
 
Only one statistically significant EEG alteration was common to all
 
three Skylab astronauts: An inflight increase in the average number of
 
beta frequency waves detected per unit of time. As with the alpha changes,
 
this finding was most pronounced in the case of Subject E.G. (84-day flight),
 
where the average inflight increase was 186%. Individual Skylab values for
 
the number of waves/see measure were as follows:
 
Number of Waves/Sec - Beta Range
 
Subject Preflight Inflight Increase p Total Range
 
J.K. (28 day) 5.7 7.3 28% <0.10 3.0
 
O.G. (59 day) 5.6 7.2 28% <0.05 4.4
 
E.G. (84 day) 2.8 8.0 186% <0.01 9.2
 
Comparison of these values with the corresponding results of the norma­
tive study (Table II) indicates that, as with the alpha, the Skylab results
 
are not atypical with respect to the overall variability, or range, of the
 
number of waves/sec parameter. With respect to Skylab Subject E.G., the pre­
flight value of 2.8 is somewhat below the normative range, while the inflight
 
average of 8.0 is actually more typical. The major inflight alteration thus
 
again appears to be (as in the case of the alpha frequency) an inflight re­
distribution or clustering of values toward the upper portion of an individual's
 
own overall range of variability for this EEG characteristic. This clustering
 
represents a significant nonrandom deviation from the expected distribution,
 
based upon the preflight results.
 
The bed-rest study results (Table VI), on the other hand, while showing a
 
similar overall variability, indicate no tendency for the values to be elevated,
 
or grouped in the upper range, during the period of bed rest.
 
With respect to the beta frequency range, it may then be concluded that
 
(1) the Skylab findings, viewed individually, are within the total range of
 
variation to be expected in a normal population; (2) the inflight measures of
 
average number of beta waveslsec, while consistently within the normal range,
 
tend to be nonrandomly clustered in the upper portion of the individual's
 
total range; and (3) such nonrandom clustering, which results in an elevation
 
of the average inflight values, was not seen in either of the subjects of the
 
bed-rest study.
 
4.5.3. The Delta Frequency Range
 
Two of the Skylab subjects showed small, but statistically significant,
 
inflight increases in the number of delta waves/unit of time measure, while
 
the third showed a similar but nonsignificant tendency. The individual aver­
age values for the number of waves/sec measure were as follows:
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Number of Waves/Sec - Delta Range
 
Subject Preflight IE light Increase p Total Range
 
J.K. (28 day) 0.7 1.0 43% <0.10 0.6
 
O.G. (59 day) 1.3 1.5 15% n.s. 0.8
 
E.G. (84 day) 0.9 1.3 44% <0.10 1.0
 
When these results are compared to Table IV, which indicates the findings
 
of the normative study with respect to the delta characteristics, it is again
 
obvious that the Skylab values are not unique with respect to their variability.
 
The significant finding is, again, a nonrandom clustering of values in the
 
upper portion of the individual ranges during the inflight period, thus result­
ing in increased values for the inflight averages. Inspection of Table VIII
 
also indicates that this tendency for a relative inflight increase in number
 
of waves/sec did not occur during a period of prolonged bed rest.
 
The conclusions are thus similar to those indicated above for the alpha
 
and beta ranges: (1) the variability of the delta range measure during Skylab
 
did not exceed the maximal range seen in a normal population, but (2) the in­
dividual inflight number of waves/sec values tended to be more concentrated in
 
the upper portion of the normal range than would be expected by random varia­
tion, and (3) this behavior did not occur during bed rest.
 
4.5.4. Conclusion
 
The results of these studies have provided quantitative confirmation of
 
the tentative conclusion made in the original report of the Skylab EEG charac­
teristics (Final Report, Part Ill, Contract NAS 9-13870): While the apparent
 
inflight EEG alterations were statistically significant, the absolute values
 
attained were never outside the range of normal variation. In addition, it is
 
clear that while some relatively minor EEG changes were seen during a period
 
of prolonged bed rest, in no instance were the alterations like those asso­
ciated with space flight.
 
ii
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2.71 10.0 9.0 
1.77 6.0 7.0 
0.65 2.0 3.0 
1.26 6.0 5.0 
1.08 3.0 3.0 
1.40 5.7 4.2
 
0.29 1.3 0.9 
0.33 1.3 1.3 
0.26 1.1 0.9 
0.20 0.9 0.7 
0.24 0.8 0.9 
0.37 1.3 1.5 
0.28 1.1 1.0
 
-TABLE III. Average Values, Control Study, Eyes Closed(1), THETA Range, n=18 
AVERAGE VALUE STD. DEV. RANGE
 
MEAN FREQUENCY (Hz) 
CIO 
(LEFT) 
C o2 (RIGHT) 
C 01 (LEFT) 
C202 (RIGHT) 
C 01 (LEFT) 
C202 (RIGHT) 
CH 2.4 2.4 0.19 0.11 0.6 0.4 
GK 2.3 2.3 0.18 0.14 0.6 0.5 
EB 2.2 2.3 0.17 0.13 0.6 0.4 
Cs 1.8 1.9 0.17 0.10 0.7 0.3 
JR 2.2 2.2 0.16 0.16 0.7 0.7 
SG 2.0 2.1 0.18 0.17 0.6 
0.6 
OVERALL 
AVERAGE 2.2 2.2 0.18 0.14 0.6 0.5 
AVERAGE AMPLITUDE (,V) 
CH 8.2 7.3 0.79 0.84 2.0 3.0 
GK 7.6 7.7 1.65 1.24 7.0 4.0 
EB 7.5 8.1 1.79 1.35 8.0 6.0 
CS 8.4 7.9 1.09 0.83 4.0 3.0 
JR 8.4 8.3 1.09 1.13 4.0 5.0 
SG 7.6 7.0 1.46 0.69 6.0 2.0 
OVERALL 
AVERAGE 8.0 7.7 1.31 1.01 5.2 3.8 
NUMBER WAVES/SEC 
CH 1.3 1.6 0.13 0.14 0.4 0.4 
GK 1.5 1.6 0.23 0.17 1.1 0.6 
EB 1.4 1.7 0.30 0.16 1.2 0.7 
CS 1.5 1.7 0.10 0.09 0.4 0.3 
JR 1.6 1.7 0.14 0.12 0.6 0.4 
SG 1.6 1.7 0.14 0.11 0.5 0.4 
OVERALL 
AVERAGE 1.5 1.7 0.17 0.13 0.7 0.5 
TABLE IV. Average Values, Control Study, Eyes Closed(I), DELTA Range, n=18 
Average Values, Bedrest Study, Awake Eyes Closed (I) 
fM N 
FREQ. (Hz) 
.H 
AVERAGE VALUE 
Pro-Study Bedrest Post-Study 
n=3 n=12 n=6 
9.7 10.0 10.1* 
STANDARD DEV. 
Pre-Study Bedrest Post-Study
n=3 n=12 n=6 
0.12 0.35 0.35 
Pre-Study
n=3 
0.2 
RANGE 
Bedrest 
n=12 
1.2 
Post-Study
n=6 
1.0 
RT 
OVERALL 
AVERAGE 
9.0 
9.4 
9.2 
9.6 
9.0 
9.6 
0.21 
0.17 
0.20 
0.28 
0.23 
0.29 
0.4 
0.3 
0.7 
1.0 
0.7 
0.9 
[AVERAGE 
AMPLITUDE 
JH 11.0 14.4 13.5 3.46 3.34' 3.27 6.0 12.0 8.0 
RT 
OVERALL 
AVERAGE 
12.3 
11.7 
13.4 
13.9 
13.0 
13.3 
1.53 
2.50 
1.62 
2.48 
2.76 
3.02 
3.0 
4.5 
5.0 
8.5 
7.0 
7.5 
NUMBER 
WAVES/SEC 
JH 
_ 
8.5 9.5*- 9.6* 0.46 0.46 0.47 0.8 1.5 1.4 
RT 
OVERALL 
AVERAGE 
7.7 
8.1 
8.0 
8.8 
8.0 
8.8 
0.58 
0.52 
0.47 
0.47 
0.38 
0.43 
1.0 
0.9 
1.9 
1.7 
1.0 
1.2 
*_0.05 
**:)<0. 02 
Channel Cl-01 ,ALPHA 
TABLE V 
Range, n=[8 
Average Values, Bedrest Study, Awake Eyes Closed (I) 
AVERAGE VALUE STANDARD DEV. RANGE 
MEAN Pro-Study Bedrest Post-Sudy Pre-Study Bedrest Post-Study Pie-Study Bedrest Post-Study
FREQ. (Hz) n=3 n=12 n=6 n=3 n=12 n=6 n=3 n:12 n=6 
.JK 20.8 20.3 20.9 0.74 0.31 1.02 1.4 0.7 2.4 
RT 19.8 20.1 19.4 0.57 0.48 0.59 1.1 18 1.4 
OVERALL I 
AVERAGE 20.3 20.2 20.2 0.66 0.40 0.81 1.3 1.3 1.9 
AVERAGE 
AMPLITUDE 
JH 8.7 8.9 8.8 2.89 1.38 2.32 5.0 4.0 6.0
 
RT 9.3 8.7 7.7** 0.58 0.98 0.52 1.0 4.0 1.0 
OVERALL 
AVERAGE 9.0 8.8 8.3 1.74 1.18 1.42 3.0 4.0 3.5 
NUbiB ER 
WAVES/SEC |___ ___ ___ 
JH 14.7 12.4 14.1 3.06 2.57 2.05 5.3 7.8 5.5 
Ri] 12.8 13.1 12.2 0.95 1.38 1.09 1.8 5.5 3.1 
OVERALL
 
AVERAGE 13.8 12.8 13.2 2.01 1.98 1.57 3.6 6.7 4.3
 
**p_0.02 Channel Cl-0, BETA Range, n=18 
TABLE VI
 
Average Values, Bedrest Study, Awake Eyes Closed (I) 
AVERAGE VALUE STANDARD DEV. RANGE 
MEAN Pro-Study Bedrest Post-Study Pre-Study Bedrest Post-Study Pre-Study Bedrest Post-Study
(Hz) n=3 n=12 n=6 n=3 n=12 n=6 n=3 n=12 n=6 
JH 5.0 5.1 5.1 0.20 0.12 0.08 0.4 0.4 0.2 
RT 5.3 5.3 5.3 0.10 0.09 0.12 0.2 0.3 0.3 
OVERALL 
AVERAGE r 5.2 5.2 5.2 0.15 0.11 0.10 0.3 0.4 0.3 
AVERAGE I 
AMPLITUDE 
JH 6.3 7.3 7.0 1.15 0.87 0.10 2.0 2.0 3.0
 
RT 10.0 10.5 9.2 1.00 1.38 2.04 2.0 4.0 5.0 
OVERALL
 
AVERAGE 8.2 8.9 8.1 1.08 1.13 1.57 2.0 3.0 4.0
 
NUMBER 
WAVES /SEC I 
JH 2.9 2.5 2.9 0.53 0.37 0.50 1.0 1.2 1.5 
RT 3.0 3.2 3.0 0.45 0.34 0.35 0.9 1.3 1.0
 
OVERALL
 
0.43 1.0 1.3 1.3
AVERAGE 3.0 2.9 3.0 0.49 0.36 

Cl-0 1 THETA 
Channel -, Range, n=18 
TABLE viI 
Average Values, Bedrest Study, Awake Eyes Closed (1) 
AVERAGE VALUE STANDARD DEV. RANGE 
MEAN Pro-Study Bedrest Post-Study Pre-Study Bedrest Post-Study Pre-Study Bedresi Post-Sfudy 
FREQ. (Hz) n=3 n=12 n-6 n=3 n=12 n=6 n=3 n=12 n=6 
JH 2.0 2.1 2.0 0.26 0.12 0.15 0.5 0.3 0.4 
RT 2.2 2.0 2.2 0.15 0.17 0.10 0.3 0.6 0.3 
OVERALL
 
2.1 2.1 0.21 0.15 0.13 0.4 0.5 0.4AVERAGE 2.1 
IAVERAGE 

I AMPLITUDE 
JH 6.0 7.1 7.5 1.00 0.79 2.74 2.0 3.0 7.0 
RT 6.3 8.3* 6.8 0.58 1.97 0.98 1.0 7.0 2.0 
OVERALL
 
7.7 7.2 0.79 1.38 1.86 1.5 5.0 4.5AVERAGE 6.2 
r NUMBER 
WAVE s / s EC 
JH 1.7 1.7 1.7 0.12 0.09 0.16 0.2 0.3 0.4
 
RT 1.4 1.5 1.6 0.15 0.16 0.12 0.3 0.5 0.3 
OVERALL
 
1.6 1.7 0.14 0.13 0.14 0.3 0.4 0.4AVERAGE 1.6 
*-Chn.n05 CI-01 DELTA
 
Channel - f_ Range, n=18
 
TABLE VIII 
